Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
47.10
-0.41 (-0.86%)
At close: May 17, 2024, 4:00 PM
48.05
+0.95 (2.02%)
After-hours: May 17, 2024, 5:44 PM EDT
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Janux Therapeutics stock have an average target of 67.14, with a low estimate of 48 and a high estimate of 100. The average target predicts an increase of 42.55% from the current stock price of 47.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for JANX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 3 | 4 | 4 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $63 | Strong Buy | Maintains | $50 → $63 | +33.76% | May 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +112.31% | May 9, 2024 |
| Wedbush | Wedbush | Buy Maintains $53 → $74 | Buy | Maintains | $53 → $74 | +57.11% | May 8, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +48.62% | Apr 16, 2024 |
| BTIG | BTIG | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +31.63% | Mar 21, 2024 |
Financial Forecast
Revenue This Year
2.02M
from 8.08M
Decreased by -75.00%
Revenue Next Year
1.31M
from 2.02M
Decreased by -35.13%
EPS This Year
-1.39
from -1.32
EPS Next Year
-1.73
from -1.39
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 5.3M | 52.5M | 26.3M | 294.0M |
| Avg | 2.0M | 1.3M | 14.0M | 12.0M | 118.0M |
| Low | n/a | n/a | n/a | n/a | 4.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -35.0% | 159.8% | 3,904.6% | 87.2% | 2,345.3% |
| Avg | -75.0% | -35.1% | 969.8% | -14.3% | 881.6% |
| Low | - | - | - | - | -59.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.98 | -1.04 | -1.30 | -2.11 | -1.31 |
| Avg | -1.39 | -1.73 | -1.98 | -2.90 | -2.60 |
| Low | -1.65 | -2.25 | -2.74 | -3.45 | -3.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.